Is trimodal therapy the current standard for muscle-invasive bladder cancer?

M López ValcárcelM Barrado Los ArcosM Ferri MolinaI Cienfuegos BelmonteV Duque SantanaP Gajate BorauJ Fernández IbizaM Álvarez MaestroP SargosF López CamposF Couñago

Published in: Actas urologicas espanolas (2024)

Trimodal therapy has shown acceptable outcomes for bladder preservation; therefore, it provides a valid treatment option in well-selected patients.

Keyphrases

muscle invasive bladder cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
spinal cord injury
prognostic factors
stem cells
adipose tissue
metabolic syndrome
patient reported outcomes
combination therapy
replacement therapy
cell therapy